Author: Nancy Humphrey
DeBruler named Vice-President of Patient Access Services, Adult Ambulatory Operations
Jan. 3, 2022—Jennifer DeBruler, MD, has been named Vanderbilt University Medical Center's new Vice-President, Patient Access Services, Adult Ambulatory Operations.
VUMC named a NORD rare disorders center of excellence
Nov. 4, 2021—by Nancy Humphrey Vanderbilt University Medical Center has been named a National Organization for Rare Disorders (NORD) Center of Excellence, joining 31 medical centers as part of an innovative network seeking to expand access and advance care and research for rare disease patients in the United States. The Vanderbilt Undiagnosed Diseases Program (VUDP), which accepts...
Clinics created to treat children with genetic disorders
Oct. 21, 2021—Vanderbilt has established clinics for children with adrenoleukodystrophy and other genetic disorders that are found on newborn screening, including Fabry disease, Krabbe disease and others.
House staff education includes focus on health equity
Sep. 30, 2021—This summer’s annual orientation for new interns, residents and fellows included a bold new discussion about the history of racism in Nashville and at Vanderbilt University Medical Center as well as topics on health equity and anti-racism in medical practice.
Study explores concussion recovery by race
Sep. 23, 2021—Vanderbilt researchers are exploring the outcomes and experiences of Black and White athletes following a sports-related concussion.
Gift creates directorship in translational vision research
Sep. 9, 2021—Marlene and Spencer Hays’ longtime support of the Vanderbilt Eye Institute includes the recent commitment to establish the Marlene & Spencer Hays Directorship in Translational Vision Research.
Law receives award for ophthalmology education excellence
Sep. 9, 2021—Vanderbilt’s Janice Law, MD, has been named to receive the Award for Excellence in Medical Student Education from the Association of University Professors of Ophthalmology (AUPO)/American Academy of Ophthalmology (AAO).
Rheumatoid arthritis drug combined with standard of care may help reduce mortality for hospitalized COVID-19 patients
Sep. 2, 2021—Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week in The Lancet Respiratory Medicine.
Initiative helps physicians interpret genetic test results
Sep. 1, 2021—A new institutional initiative will offer a secure and easy way for physicians at Vanderbilt University Medical Center to ask for help interpreting genetic test results for their patients.
Using Patients’ Allergy History as Screening Tool for mRNA COVID-19 Vaccine Works Well: Study
Jul. 27, 2021—A report of more than 23,000 health care workers and employees at Vanderbilt University Medical Center who received the Pfizer-BioNTech mRNA COVID-19 vaccine shows that a risk stratification screening mechanism for potential allergies to the vaccine worked exceedingly well as the vaccine program rolled out in December 2020.
Allergic reaction to first dose of an mRNA COVID-19 vaccine should not keep people from getting the second dose: study
Jul. 26, 2021—An immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine — those manufactured by Moderna and Pfizer BioNTech — should not keep people from getting the second dose, a multi-hospital analysis shows.
Study finds children ingested small objects like coins and batteries more frequently during the pandemic
Jul. 14, 2021—Foreign bodies, like coins, button batteries, tiny magnets and sharp objects, were more frequently ingested by children during the coronavirus pandemic than in the same months the year before, according to a single-center study conducted at Monroe Carell Jr. Children’s Hospital at Vanderbilt.